[LXRX] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
14-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 39.00%
YoY- 40.87%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 14 199 8,727 17,071 33,047 23,037 127,280 -78.08%
PBT -25,611 -5,495 -51,138 -16,781 -32,387 -32,419 86,750 -
Tax -14 -174 335 -102 -4,009 37 1,612 -
NP -25,611 -5,495 -51,138 -16,781 -28,378 -32,419 86,750 -
Tax Rate - - - - - - -1.86% -
Total Cost 25,625 5,694 59,865 33,852 61,425 55,456 40,530 -7.35%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -182,935.71 -2,761.31 -585.97 -98.30 -85.87 -140.73 68.16 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.17 -0.04 -0.48 -0.16 -0.27 -0.31 0.84 -
EPS Diluted -0.17 -0.04 -0.48 -0.16 -0.27 -0.31 0.76 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.